Evidence map›Paper›PMID 12486173›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2002

Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive.

Tom R Hollon, Martin J Bek, Jean E Lachowicz, Marjorie A Ariano, Eva Mezey, Ramesh Ramachandran, Scott R Wersinger, Patricio Soares-da-Silva, Zhi Fang Liu, Alexander Grinberg and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 156 citations in OpenAlex.

  1. Cardiovascular pharmacology of dopaminergic agents in humans: a review.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Role of Dopamine in the Heart in Health and Disease.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Dopamine DHypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  12. Reversible Treatment of Pressure Overload-Induced Left Ventricular Hypertrophy throughAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  13. Review
  14. Review
  15. Sorting nexin 1 loss results in increased oxidative stress and hypertension.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  16. Article
  17. Review
  18. Role of Thioredoxin 1 in Impaired Renal Sodium Excretion of hDJournal of the American Heart Association · 2019
    Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

Tom R HollonMolecular Neuropharmacology Section and Basic Neurosciences Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1406, USA.
Martin J Bek
Jean E Lachowicz
Marjorie A Ariano
Eva Mezey
Ramesh Ramachandran
Scott R Wersinger
Patricio Soares-da-Silva
Zhi Fang Liu
Alexander Grinberg
John Drago
W Scott Young
Heiner Westphal
Pedro A Jose
David R Sibley
Molecular Oncology (United States) · USNational Institute of Mental Health · USNational Institutes of Health · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USGeorgetown University · USGeorgetown University Medical Center · USInstituto Português de Oncologia Francisco Gentil · PTNational Institute of Neurological Disorders and Stroke · USRosalind Franklin University of Medicine and Science · US

Funding

Molecular And Pharmacological Studies Of Dopamine ReceptorsZIANS002263 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SIBLEY, DAVID · 2009 to 2025
$37.4M
Roles of Oxytocin and Vasopressin in BrainZIAMH002498 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI YOUNG, WALTER SCOTT · 2009 to 2022
$26.3M
Mammalian Developmental Genetics and Stem CellsZIAHD000071 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI WESTPHAL, HEINER · 2009 to 2012
$8.5M
REGULATION OF GENE EXPRESSION IN THE ADENOVIRUS SYSTEM AND IN TRANSGENIC MICEZ01HD000071 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI WESTPHAL, HEINER · 1985 to 2008
$4.4M
REGULATION OF GENE EXPRESSION IN THE BRAINZ01MH002498 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI YOUNG, WALTER SCOTT · 1990 to 2008
$3.2M
Molecular &Pharmacological Studies Of Dopamine ReceptorZ01NS002263 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI SIBLEY, DAVID R. · 1985 to 2008
$3.1M
6 · The paper itself

Abstract

Dopamine is an important transmitter in the CNS and PNS, critically regulating numerous neuropsychiatric and physiological functions. These actions of dopamine are mediated by five distinct receptor subtypes. Of these receptors, probably the least understood in terms of physiological functions is the D5 receptor subtype. To better understand the role of the D5 dopamine receptor (DAR) in normal physiology and behavior, we have now used gene-targeting technology to create mice that lack this receptor subtype. We find that the D5 receptor-deficient mice are viable and fertile and appear to develop normally. No compensatory alterations in other dopamine receptor subtypes were observed. We find, however, that the mutant mice develop hypertension and exhibit significantly elevated blood pressure (BP) by 3 months of age. This hypertension appears to be caused by increased sympathetic tone, primarily attributable to a CNS defect. Our data further suggest that this defect involves an oxytocin-dependent sensitization of V1 vasopressin and non-NMDA glutamatergic receptor-mediated pathways, potentially within the medulla, leading to increased sympathetic outflow. These results indicate that D5 dopamine receptors modulate neuronal pathways regulating blood pressure responses and may provide new insights into mechanisms for some forms of essential hypertension in humans, a disease that afflicts up to 25% of the aged adult population in industrialized societies.

Indexed as

Adrenal GlandsAnimalsBlood PressureBrainBrain ChemistryEpinephrineGene TargetingHypertensionImmunohistochemistryMiceMice, Inbred C57BLMice, KnockoutNorepinephrineOxytocinReceptors, Dopamine D1Receptors, Dopamine D2Drd5 protein, mouseEpinephrineNorepinephrineOxytocinReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Dopamine D5Receptors, OxytocinReceptors, VasopressinRNA, MessengerVasopressins

Identifiers

PMID12486173
PMCPMC6758465
OpenAlexW2131745632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.